Laboratoire DIPO SPRL
Laboratoire DIPO reported total assets of 24,259 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Sep 2026).
The score of Laboratoire DIPO shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +5 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Laboratoire DIPO's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Sep 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 19 Jul 2023
- Year ended 31 Dec 2021filed on 27 Jul 2022
Laboratoire DIPO's financial analysis
- Solvency98.3%sector median: -10.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Laboratoire DIPO
Laboratoire DIPO's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0887.494.966
- VAT number
- BE0887494966
- Peppol
- Registered · 0208:0887494966 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 26 Feb 2007
- Registered office
- 1040 Etterbeek
- Latest accounts
- 2025 · filed on 24 Sep 2026
- Activity
- Manufacture of perfume and toilet preparations (NACE 20420)
Laboratoire DIPO (SPRL) has been based in Etterbeek since 2007, active in: manufacture of perfume and toilet preparations. For 2025, it reports a net profit of 774 € and equity of 23,847 €; its revenue is not published. Its solvency stands at 98.3%, above the median of its sector (-10.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Laboratoire DIPO
Companies in the same business, of comparable size and area, outside its group.
- LABO DéESSE Manufacture of perfume and toilet preparations Beveren-Kruibeke-Zwijndrecht · balance sheet 799,197 €
- Asterion Therapeutics Manufacture of pharmaceutical preparations Beveren-Kruibeke-Zwijndrecht · balance sheet 58,464 €
- Conscio Manufacture of perfume and toilet preparations Tervuren · balance sheet 45,038 €
- Deutarium Manufacture of perfume and toilet preparations Villers-la-Ville · balance sheet 19,970 €
- Cerepharma Manufacture of perfume and toilet preparations Ath · balance sheet €1.52m
- Misoty Manufacture of perfume and toilet preparations Anderlecht · balance sheet 46,150 €
- Artéssence Manufacture of perfume and toilet preparations Brussels · balance sheet 63,683 €
- Sygibel Manufacture of perfume and toilet preparations Ixelles · balance sheet 573,750 €
Frequently asked questions about Laboratoire DIPO
What is the revenue of Laboratoire DIPO?
Laboratoire DIPO files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Laboratoire DIPO?
In Belgium, the VAT number is the company number prefixed with BE: BE0887494966 for Laboratoire DIPO, if the company is VAT-registered. Its company number (CBE) is 0887.494.966.
Where is the registered office of Laboratoire DIPO?
According to the CBE register, the registered office of Laboratoire DIPO is in 1040 Etterbeek.
What is the equity of Laboratoire DIPO?
At the close of the 2025 financial year, the equity of Laboratoire DIPO amounts to 23,847 €, a solvency of 98.3% of total assets.
Who manages Laboratoire DIPO?
The register lists 1 active mandates at Laboratoire DIPO. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Laboratoire DIPO
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →